RA Capital Management
Overview
RA Capital Management is a multi-stage investment firm based in Boston, Massachusetts, dedicated to evidence-based investing in public and private healthcare and life sciences companies. The firm focuses on developing drugs, medical devices, diagnostics, services, and research tools, supporting companies from seed stage to public markets. RA Capital's internal research division, TechAtlas, analyzes scientific and clinical data to inform investment decisions, while its healthcare incubator, Raven, offers entrepreneurs a collaborative platform to build innovative companies. As of March 2025, the firm manages over $12.6 billion in assets and employs approximately 130 professionals. RA Capital's portfolio includes investments in various therapeutic areas, reflecting its commitment to advancing healthcare solutions globally.
Investment Focus
- Evidence-based scientific approach
- Strong management teams
- Innovative technologies
- Scalable business models
- Global market potential
- Regulatory compliance
- Clear exit strategies
- Alignment with RA Capital's mission and values
- Commitment to improving patient outcomes
- Sustainable financial performance
Portfolio Companies
Reach RA Capital Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about RA Capital Management
What sectors does RA Capital Management invest in?
RA Capital Management invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Media, and is based in Massachusetts, United States. RA Capital Management is listed as a private equity in the ConnectSafely investor database.
What stage does RA Capital Management invest at?
RA Capital Management backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 500M.
Which regions does RA Capital Management invest in?
RA Capital Management invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at RA Capital Management?
Team members listed for RA Capital Management include Brent Sanders (Chief Information Officer) and Michael Saulnier (Chief Financial Officer).
What companies has RA Capital Management invested in?
RA Capital Management's portfolio includes Sana Biotechnology, Sutro Biopharma, Arcellx, Beam Therapeutics, Moderna, Alnylam Pharmaceuticals, Editas Medicine and Sarepta Therapeutics.
How do I contact RA Capital Management?
RA Capital Management's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
